This retrospective, multi-center study investigated the patterns and outcomes of medical cannabis use among pediatric and adult patients in California under direct physician supervision. Four experienced cannabis clinicians, who adhere to the medical cannabis standard of care, have collected data on over 600 patients using cannabinoid-based treatments. We partnered with the UCLA Center for Cannabis and Cannabinoids for evaluation of the data. We analyzed patient diagnoses, access points (e.g., delivery vs. in-person dispensaries), preferred product formulations, cannabinoid content, patient use patterns and their correlation with specific medical conditions or symptoms.

We are still currently analyzing the data and will have results early spring 2025, which will then be published.

Our findings (so far) have revealed the following:

1. Most common diagnoses in adults include chronic pain, cancer, MS, anxiety/depression and insomnia
2. Most common diagnoses in the pediatric population include intractable epilepsy, autism and cancer
3. Only two patients out of the over 600 that participated required emergency department visit for side effects
4. The vast majority of patients are aware of the make-up of their cannabis products
5. A significant number of patients report being able to reduce or eliminate prescription medications
6. 83% of patients report medical cannabis to be very effective or effective Additional findings will be presented pending completion of the study

Additional findings will be presented pending completion of the study.

Learning Objectives:

• Analyze the diverse medical conditions treated with cannabis among 600+ patients
• Explore how specific diagnoses influence product choice and treatment outcomes
• Identify the reported benefits, side effects, and barriers to access